Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nationwide seroprevalence of antibodies against SARS-CoV-2 in Israel
Shay Reicher, Ronit Ratzon, Shay Ben-Sahar, et al.
European Journal of Epidemiology (2021) Vol. 36, Iss. 7, pp. 727-734
Open Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

Age-stratified infection fatality rate of COVID-19 in the non-elderly population
Angelo Maria Pezzullo, Cathrine Axfors, Despina G. Contopoulos‐Ioannidis, et al.
Environmental Research (2022) Vol. 216, pp. 114655-114655
Open Access | Times Cited: 95
Infection fatality rate of COVID-19 in community-dwelling elderly populations
Cathrine Axfors, John P. A. Ioannidis
European Journal of Epidemiology (2022) Vol. 37, Iss. 3, pp. 235-249
Open Access | Times Cited: 53
COVID-19 prevalence and mortality in longer-term care facilities
Andrew Levin, Juulia Jylhävä, Dorota Religa, et al.
European Journal of Epidemiology (2022) Vol. 37, Iss. 3, pp. 227-234
Open Access | Times Cited: 38
Nationally representative SARS-CoV-2 antibody prevalence estimates after the first epidemic wave in Mexico
Ana Basto‐Abreu, Martha Carnalla, Leticia Torres‐Ibarra, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 34
Modelling COVID-19 vaccine breakthrough infections in highly vaccinated Israel—The effects of waning immunity and third vaccination dose
Anyin Feng, Uri Obolski, Lewi Stone, et al.
PLOS Global Public Health (2022) Vol. 2, Iss. 11, pp. e0001211-e0001211
Open Access | Times Cited: 26
Differential COVID-19 infection rates in children, adults, and elderly: Systematic review and meta-analysis of 38 pre-vaccination national seroprevalence studies
Cathrine Axfors, Angelo Maria Pezzullo, Despina G. Contopoulos‐Ioannidis, et al.
Journal of Global Health (2023) Vol. 13
Open Access | Times Cited: 12
SARS-CoV-2 Seroprevalence Structure of the Russian Population during the COVID-19 Pandemic
Anna Y. Popova, В. С. Смирнов, E.E. Andreeva, et al.
Viruses (2021) Vol. 13, Iss. 8, pp. 1648-1648
Open Access | Times Cited: 31
COVID-19 vaccination in Israel
Khitam Muhsen, Dani Cohen
Clinical Microbiology and Infection (2021) Vol. 27, Iss. 11, pp. 1570-1574
Open Access | Times Cited: 30
A global assessment of the impact of school closure in reducing COVID-19 spread
Joseph T. Wu, Shujiang Mei, Sihui Luo, et al.
Philosophical Transactions of the Royal Society A Mathematical Physical and Engineering Sciences (2021) Vol. 380, Iss. 2214
Open Access | Times Cited: 28
Long-Term Antibody Response to SARS-CoV-2 in Children
Gábor A. Dunay, Madalena Barroso, Mathias Woidy, et al.
Journal of Clinical Immunology (2022) Vol. 43, Iss. 1, pp. 46-56
Open Access | Times Cited: 18
SARS-CoV-2 seroprevalence in Portugal following the third epidemic wave: results of the second National Serological Survey (ISN2COVID-19)
Irina Kislaya, Paulo Gonçalves, Verónica Gómez, et al.
Infectious Diseases (2022) Vol. 54, Iss. 6, pp. 418-424
Closed Access | Times Cited: 15
Structural factors associated with SARS-CoV-2 infection risk in an urban slum setting in Salvador, Brazil: A cross-sectional survey
Mariam O. Fofana, Nívison Nery, Juan P. Aguilar Ticona, et al.
PLoS Medicine (2022) Vol. 19, Iss. 9, pp. e1004093-e1004093
Open Access | Times Cited: 13
Seroprevalence of anti-SARS-CoV-2 antibodies in Thai adults during the first three epidemic waves
Hatairat Lerdsamran, Anek Mungaomklang, Sopon Iamsirithaworn, et al.
PLoS ONE (2022) Vol. 17, Iss. 4, pp. e0263316-e0263316
Open Access | Times Cited: 12
COVID-19 in Tunisia (North Africa): Seroprevalence of SARS-CoV-2 in the General Population of the Capital City Tunis
Ines Cherif, Ghassen Kharroubi, Sana Châabane, et al.
Diagnostics (2022) Vol. 12, Iss. 4, pp. 971-971
Open Access | Times Cited: 12
National and regional prevalence of SARS-CoV-2 antibodies in primary and secondary school children in England: the School Infection Survey, a national open cohort study, November 2021SARS-CoV-2 antibody prevalence in school children
Annabel Powell, Georgina Ireland, Rebecca Leeson, et al.
Journal of Infection (2023) Vol. 86, Iss. 4, pp. 361-368
Open Access | Times Cited: 7
Nationwide increases in anti-SARS-CoV-2 IgG antibodies between October 2020 and March 2021 in the unvaccinated Czech population
Pavel Piler, Vojtěch Thon, Lenka Andrýsková, et al.
Communications Medicine (2022) Vol. 2, Iss. 1
Open Access | Times Cited: 11
Sero‐prevalence of SARS‐CoV‐2 in certain cities of Kazakhstan
Manar Smagul, Aizhan Esmagambetova, Gauhar Nusupbaeva, et al.
Health Science Reports (2022) Vol. 5, Iss. 2
Open Access | Times Cited: 11
Trajectories of Seroprevalence and Neutralizing Activity of Antibodies against SARS-CoV-2 in Southern Switzerland between July 2020 and July 2021: An Ongoing, Prospective Population-Based Cohort Study
Rebecca Amati, Giovanni Piumatti, Giovanni Franscella, et al.
International Journal of Environmental Research and Public Health (2023) Vol. 20, Iss. 4, pp. 3703-3703
Open Access | Times Cited: 5
Academic activism on behalf of children during the COVID-19 pandemic in Israel; beyond public health advocacy
Ora Paltiel, Hagit Hochner, David Chinitz, et al.
Israel Journal of Health Policy Research (2021) Vol. 10, Iss. 1
Open Access | Times Cited: 11
SARS-CoV-2 infections in 165 countries over time
Stilianos Louca
International Journal of Infectious Diseases (2021) Vol. 111, pp. 336-346
Open Access | Times Cited: 9
Educational intervention for the main caregiver of primiparous women to promote breastfeeding and the association between prolactin and nutritional parameters
Eva Pilar López, Sergio González, Mercedes Sánchez
Journal of Global Health (2023) Vol. 13
Open Access | Times Cited: 3
Inferring the COVID-19 infection fatality rate in the community-dwelling population: a simple Bayesian evidence synthesis of seroprevalence study data and imprecise mortality data
Harlan Campbell, Paul Gustafson
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 7
Spatio-temporal spread of COVID-19: Comparison of the inhomogeneous SEPIR model and data from South Carolina
Yoav Tsori, Rony Granek
PLoS ONE (2022) Vol. 17, Iss. 6, pp. e0268995-e0268995
Open Access | Times Cited: 5
Age-stratified infection fatality rate of COVID-19 in the non-elderly informed from pre-vaccination national seroprevalence studies
Angelo Maria Pezzullo, Cathrine Axfors, Despina G. Contopoulos‐Ioannidis, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 5
Differential COVID-19 infection rates in children, adults, and elderly: evidence from 38 pre-vaccination national seroprevalence studies
Cathrine Axfors, Angelo Maria Pezzullo, Despina G. Contopoulos‐Ioannidis, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top